CYP2E1 and risk of chemically mediated cancers

Bibliography

• Nelson DR, Koymans L, Kamataki T, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996;6:1-42
   PubMedGoogle Scholar
• Yun CH, Miller GP, Guengerich FP. Oxidations of palkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure–activity relationships and simulation of rate constants of individual steps in catalysis. Biochemistry 2001;40:4521-30
   PubMed Web of Science ®Google Scholar
• Klingenberg M. Pigments of rat liver microsomes. Arch Biochem Biophys 1958;75:376
   PubMed Web of Science ®Google Scholar
• Garfinkel D. Studies on pig liver microsomes. I. Enzymic and pigment composition of different microsomal fractions. Arch Biochem Biophys 1958;77:493-509
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. A new cytochrome in liver microsomes. J Biol Chem 1962;237:1375-6
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem 1964;239:2379-85
   PubMed Web of Science ®Google Scholar
• Porter TD. Jud Coon: 35 years of P450 research, a synopsis of P450 history. Drug Metab Dispos 2004;32:1-6
   PubMed Web of Science ®Google Scholar
• Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997;77:517-44
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005;569:101-10
   PubMed Web of Science ®Google Scholar
• Lieber CS. Mechanisms of ethanol-drug nutrition interactions. Clin Toxicol 1994;32:631-81
   Web of Science ®Google Scholar
• Ronis MIJ, Lindros KO, Ingelman-Sundberg M. The CYP2E subfamily. In: Ioannides C, editor, Cytochromes P-450: metabolic and toxicological aspects. CRC Press, New York, 1996; p. 211-39
   Google Scholar
• Ghanayem BI, Wang H, Sumner S. Using cytochrome P-450 gene knock-out mice to study chemical metabolism, toxicity, and carcinogenicity. Toxicol Pathol 2000;28:839-50
   PubMed Web of Science ®Google Scholar
• B.J. Song, Gene structure and multiple regulation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) subfamily. In: Watson RR, editor, Drug and alcohol abuse review. Alcohol and hormones. (Volume 6). Humana Press Inc., Totowa, NJ; 1995. p. 177-92
   Google Scholar
• Johansson I, Eliasson E, Norsten C, Hydroxylation of acetone by ethanoland acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. FEBS Lett 1986;196:59-64
   PubMed Web of Science ®Google Scholar
• Nakajima T, Elovaara E, Park SS, Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis 1989;10:1713-17
   PubMed Web of Science ®Google Scholar
• Raucy JL, Kraner JC, Lasker JM. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 1993;23:1-20
   PubMed Web of Science ®Google Scholar
• Kharasch ED. Biotransformation of sevoflurane. Anesth Analg 1995;81(Suppl):S27-38
   PubMedGoogle Scholar
• Garton KJ, Yuen P, Meinwald J, Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1. Drug Metab Dispos 1995;23:1426-30
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 1993;79:795-807
   PubMed Web of Science ®Google Scholar
• Peter R, Bocker R, Beaune PH, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 1990;3:566-73
   PubMed Web of Science ®Google Scholar
• Tanaka E, Funae Y. Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity. Methods Enzymol 1996;272:163-9
   PubMed Web of Science ®Google Scholar
• Lucas D, Farez C, Bardou LG, Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam Clin Pharmacol 1998;12:553-8
   PubMed Web of Science ®Google Scholar
• Mandl J, Banhegyi G, Kalapos MP, Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chem Biol Interact 1995;96:87-101
   PubMed Web of Science ®Google Scholar
• McCarver DG, Byun R, Hines RN, A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 1998;152:276-81
   PubMed Web of Science ®Google Scholar
• Bolt HM, Roos PH, Thier R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 2003;76:174-85
   PubMed Web of Science ®Google Scholar
• Meskar A, Plee-Gautier E, Amet Y, Alcohol-xenobiotic interactions. Role of cytochrome P450 2E1. Pathol Biol (Paris) 2001;49:696-702
   PubMed Web of Science ®Google Scholar
• Constan AA, Sprankle CS, Peters JM, Metabolism of chloroform by cytochrome P4502E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol Appl Pharmacol 1999;160:120-6
   PubMed Web of Science ®Google Scholar
• Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol Appl Pharmacol 1998;153:109-18
   PubMed Web of Science ®Google Scholar
• Ghanayem BI, Sanders JM, Chanas B, Role of cytochrome P-450 2E1 in methacrylonitrile metabolism and disposition. J Pharmacol Exp Ther 1999;289:1054-9
   PubMed Web of Science ®Google Scholar
• Srumner SC, Fennell TR, Moore TA, Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999;12:1110-16
   PubMed Web of Science ®Google Scholar
• Bernauer U, Vieth B, Ellrich R, CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism. Arch Toxicol 1999;73:189-96
   PubMed Web of Science ®Google Scholar
• Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 1999;424:127-42
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Hecht SS. Handbook of experimental pharmacology. Springer, Heidelberg; 1990
   Google Scholar
• Rivenson A, Hoffmann D, Prokopczyk B, Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988;48:6912-7
   PubMed Web of Science ®Google Scholar
• Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 1989;8:273-94
   PubMedGoogle Scholar
• Kang JS, Wanibuchi H, Morimura K, Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res 2007;7:11141-6
   Web of Science ®Google Scholar
• Rodriguez-Antona C, Ingelman-Sunberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006;25:1679-91
   PubMed Web of Science ®Google Scholar
• World Health Organization. Acrylonitrile: Environmental Health Criteria, Report 28, World Health Organization, Geneva, Switzerland, 1983
   Google Scholar
• Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P452E1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991;4:168-79
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Geiger LE, Hogy LL, In vitro metabolism of acrylonitrile to 2-cyanoethylene oxide, reaction with glutathione, and irreversible binding to proteins and nucleic acids. Cancer Res 1981;41:4925-33
   PubMed Web of Science ®Google Scholar
• Kedderis GL, Batra R, Koop DR. Epoxidation of acrylonitrile by rat and human cytochrome P-450. Chem Res Toxicol 1993;6:866-71
   PubMed Web of Science ®Google Scholar
• Ghanayem BI, Sanchez IM, Burka LT. Effects of dose, strain, and dosing vehicle on methacrylonitrile disposition in ratsand identification of a novel-exhaled metabolite. Drug Metab Dispos 1992;20:643-52
   PubMed Web of Science ®Google Scholar
• Settels E, Bernauer U, Palavinskas R, Human CYP2E1 mediates the formation of glycidamide from acrylamide. Arch Toxicol 2008;2:717-27
   Web of Science ®Google Scholar
• National Cancer Institute. Report on Carcinogenesis Bioassay of Chloroform. CAS No 67-66-3. Gavage Studies. National Technical Information Service No. PB264018/AS, National Institutes of Health, Bethesda, Maryland, 1976
   Google Scholar
• Bondoc FY, Bao ZP, Hu WY, Acetone catabolism by cytochrome P-450 2E1: Studies with CYP2E1-null mice. Biochem Pharmacol 1999;58:461-3
   PubMed Web of Science ®Google Scholar
• Brambilla G, Sciabà L, Faggin P, Methylglyoxal-induced DNA-protein cross-links and cytotoxicity in Chinese hamster ovary cells. Carcinogenesis 1985;6:683-6
   PubMed Web of Science ®Google Scholar
• Kang JH. Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicol Lett 2003;145:181-7
   PubMed Web of Science ®Google Scholar
• Kligerman AD, Hu Y. Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites. Chem Biol Interact 2007;166:132-9
   PubMed Web of Science ®Google Scholar
• Jackson TE, Schlosser PM, Medinsky MA, Assessing the role of CYP2E1 in the metabolism and genotoxicity of 1,3-butadiene. Toxicol Sci 1999;48:110
   Google Scholar
• Mendoza-Cantú A, Castorena-Torres F, Bermúdez deLeon M, Occupational toluene exposure induces cytochrome p450 2e1 mrna expression in peripheral lymphocytes. Environ Health Perspect 2006;114:494-9
   PubMed Web of Science ®Google Scholar
• Nakajima T, Wang RS. Induction of cytochrome P450 by toluene. Int J Biochem 1994; 26:1333-40
   PubMedGoogle Scholar
• Gonzalez-Jasso E, Lopez T, Lucas D, CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes. Toxicol Lett 2003;144:55-67
   PubMed Web of Science ®Google Scholar
• Kang JH. Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicol Lett 2003;145:181-7
   PubMed Web of Science ®Google Scholar
• Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991;110:559-65
   PubMed Web of Science ®Google Scholar
• Uematsu F, Kikuchi H, Motomiya M, Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991;82:254-6
   PubMedGoogle Scholar
• Watanabe J, Hayashi SI, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. Biochem J 1994;116:321-6
   Google Scholar
• Garte S, Gaspari L, Alexandrie AK, Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Hanaoka T, Ohnami S, Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J Hum Genet 2003;48:654-8
   PubMed Web of Science ®Google Scholar
• Ran L, Li-hong Y, Yue-pu P. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Chin Med J 2007;120:1797-802
   PubMed Web of Science ®Google Scholar
• Kato S, Shields PG, Caporaso NE, Cytochrome P450IIEI genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992;52:6712-5
   PubMed Web of Science ®Google Scholar
• Carriere V, Berthou F, Baird S, Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 1996;6:203-11
   PubMedGoogle Scholar
• Tsutsumi M, Takada A, Wang JS. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994;107:1430-5
   PubMed Web of Science ®Google Scholar
• Persson I, Johansson I, Bergling H, Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett 1993;319:207-11
   PubMed Web of Science ®Google Scholar
• Parsian A, Oninger CR, Zhang ZH. Association studies of polymorphisms of CYP2E1 gene in alcoholics with cirrhosis, antisocial personality, and normal controls. Alcohol Clin Exp Res 1998;22:888-91
   PubMed Web of Science ®Google Scholar
• Uematsu F, Ikawa S, Kikuchi S, Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: Possible relevance to low smoking exposure. Pharmacogenetics 1994;4:58-63
   PubMedGoogle Scholar
• Hildesheim A, Anderson LM, Chen CJ, CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-12
   PubMed Web of Science ®Google Scholar
• Wong NACS, Rae F, Simpson KJ, Genetic polymorphism of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol 2000;53:88-93
   PubMedGoogle Scholar
• Neuhaus T, Ko Y-D, Lorenzen K, Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett 2004;151:273-82
   PubMed Web of Science ®Google Scholar
• Ruwali M, Khan AJ, Shah PP, Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environ Mol Mutagen 2009;50:473-82
   PubMed Web of Science ®Google Scholar
• Morita M, Le Marchand L, Kono S, Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev 2009;18:235-41
   PubMed Web of Science ®Google Scholar
• Kiss I, Orsos Z, Gombos K, Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 2007;27:2931-7
   PubMed Web of Science ®Google Scholar
• Ferreira PM, Catarino R, Pereira D, Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology. Eur J Clin Pharmacol 2006;62:15-21
   PubMed Web of Science ®Google Scholar
• Qin JM, Yang L, Chen B, Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol 2008;14:6986-92
   PubMed Web of Science ®Google Scholar
• Guo YM, Wang Q, Liu YZ, Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. World J Gastroenterol 2008;14:1444-9
   PubMed Web of Science ®Google Scholar
• Li D, Dandara C, Parker MI. Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus. Clin Chem Lab Med 2005;43:370-5
   PubMed Web of Science ®Google Scholar
• Gao C, Takezaki T, Wu J, Interaction between cytochrome p-450 2e1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 2002;11:29-34
   PubMed Web of Science ®Google Scholar
• Liu R, Yin LH, Pu YP. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Hauai'an population, China. Chin Med J 2007;120:1797-802
   PubMed Web of Science ®Google Scholar
• Park GT, Lee OY, Kwon SJ, Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans. J Gastroenterol Hepatol 2003;18:1257-63
   PubMed Web of Science ®Google Scholar
• Soya SS, Vinod T, Reddy KS, CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics 2008;9:551-60
   PubMed Web of Science ®Google Scholar
• Eom SY, Zhang YW, Kim SH, Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control 2009;20:137-45
   PubMed Web of Science ®Google Scholar
• Liu S, Park JY, Schantz SP. Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 2001;37:437-45
   PubMed Web of Science ®Google Scholar
• Wang YH, Yeh SD, Shen KH, A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Toxicol Appl Pharmacol 2009;241:111-8
   PubMed Web of Science ®Google Scholar
• Ulusoy G, Adali O, Tumer TB, Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Oncology 2007;72:125-31
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Sinnett H, Richer C, Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002;97:230-6
   PubMed Web of Science ®Google Scholar
• Wang Y, Millonig G, Nair J, Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 2009;50:453-61
   PubMed Web of Science ®Google Scholar
• Druesne-Pecollo N, Tehard B, Mallet Y, Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 2009;10:173-80
   PubMed Web of Science ®Google Scholar
• Seitz HK, Cho CH. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 2009;472:217-41
   PubMedGoogle Scholar
• Koop DR. Oxidative and reductive metabolism by cytochrome P-450 2E1. FASEB J 1992;6:724-30
   PubMed Web of Science ®Google Scholar
• Cederbaum AI, Wu D, Mari M, CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001;31:1539-43
   PubMed Web of Science ®Google Scholar
• Bradford BU, Kono H, Isayama F, Cytochrome P-450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol induced oxidative DNA damage in rodent liver. Hepatology 2005;41:336-44
   PubMed Web of Science ®Google Scholar
• Yoo JSH, Guengerich FP, Yang CS. Metabolism of N-nitrosodialkylamines by human liver microsomes. Cancer Res 1988;48:1499-504
   PubMed Web of Science ®Google Scholar
• Hunt CM, Strater S, Stave EM. Effect of normal aging on the activity of human hepatic cytochrome P450IIE1. Biochem Pharmacol 1990;10:1666-9
   Web of Science ®Google Scholar
• Kim RB, O'Shea D, Wilkinson GR. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 1995;57:645-55
   PubMed Web of Science ®Google Scholar
• Girre C, Lucas D, Hispard E, et el. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994;47:1503-8
   PubMed Web of Science ®Google Scholar
• O'Shea D, Davis SN, Kim RB, Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 1994;56:359-67
   PubMed Web of Science ®Google Scholar
• Dilger K, Metzler J, Bode JC, CYP2E1 activity in patients with alcoholic liver disease. J Hepatol 1997;27:1009-14
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Thummel KE, Mhyre J, Single dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P4502E1. Clin Pharmacol Ther 1993;53:643-50
   PubMed Web of Science ®Google Scholar
• Gerhardt AC, Lucas D, Menez J-F, Chlormethiazole inhibition of cytochrome P4502E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 1997;26:957-61
   PubMed Web of Science ®Google Scholar
• Eap CB, Schnyder C, Besson J, Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Clin Pharmacol Ther 1998;64:52-7
   PubMed Web of Science ®Google Scholar
• Leclercq I, Desago J-P, Horsman Y. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin Pharmacol Ther 1998;64:144-19
   PubMed Web of Science ®Google Scholar
• Bogaards JJP, van Immen B, van Bladeren PJ. Interindividual differences in the in vitro conjugation of methylene chloride with glutathione S-transferase in 22 human liver samples. Biochem Pharmacol 1993;45:2166-9
   PubMed Web of Science ®Google Scholar
• Kim RB, Yamazaki H, Chiba K, In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 1996;279:4-11
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Wilkens LR, Kolonel LN. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomark Prev 1992;1:103-7
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Kolonel LN. Cancer among Japanese migrants to Hawaii: gene-environment interactions. Rev Epidemiol Sante Publique 1992;40:425-30
   PubMed Web of Science ®Google Scholar
• Uematsu F, Kikuchi H, Motomiya M, Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn Cancer Res 1991;82:254-6
   Web of Science ®Google Scholar
• Wu X, Shi H, Jiang H, Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997;18:967-73
   PubMed Web of Science ®Google Scholar
• Wu XF, Amos CI, Kemp BL, Cytochrome P450 2E1 DraI polymorphism in lung cancer in minority populations. Cancer Epidemiol Biomark Prev 1998;7:13-8
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Sivaraman L, Pierce L, Associations of CYP1A1, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998;58:4858-63
   PubMed Web of Science ®Google Scholar
• Brady JF, Xiao F, Wang MH, Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol Appl Pharmacol 1991;108:366-73
   PubMed Web of Science ®Google Scholar
• Eneanya DI, Bianchine JR, Duran DO, The actions and metabolic fate of disulfiram. Annu Rev Pharmacol Toxicol 1981;21:575-96
   PubMed Web of Science ®Google Scholar
• Valentine WM, Amarnath V, Amarnath K, Characterization of protein adducts produced by N-methyldithiocarbamate and N-methyldithiocarbamate esters. Chem Res Toxicol 1995;8:254-61
   PubMed Web of Science ®Google Scholar
• Winters DK, Cederbaum AI. Time course characterization of the induction of cytochrome P-4502E1 by pyrazole and 4- methylpyrazole. Biochem Biophys Acta 1992;1117:15-24
   PubMed Web of Science ®Google Scholar
• Heinemann F, Assion HJ. Hepatotoxic side-effect of chlormethiazole. Pharmacopsychiatry 1996;29:196-7
   PubMed Web of Science ®Google Scholar
• Davenport DM, Wargovich MJ. Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food Chem Toxicol 2005;43:1753-62
   PubMed Web of Science ®Google Scholar
• Karamanakos PN, Trafalis DT, Geromichalos GD, Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1- butanone (NNK)-induced mutagenicity. Arch Toxicol 2009;83:571-80
   PubMed Web of Science ®Google Scholar